27 insiders reported 67 Form 4 transactions for COGNITION THERAPEUTICS INC (CGTX) over the past 18 months (most recent 2026-06-22). Recent activity: Monia Brett P (Director) Buy 25,000 shares, Wallace Peggy (Director) Buy 25,000 shares, Khattar Jack A. (Director) Buy 25,000 shares, BIOS Memory SPV I, LP (Director) Buy 25,000 shares, BIOS Fund I, LP (Director) Buy 25,000 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-22 | Monia Brett P | Director | Buy | 25,000 | $0 |
| 2026-06-22 | Wallace Peggy | Director | Buy | 25,000 | $0 |
| 2026-06-22 | Khattar Jack A. | Director | Buy | 25,000 | $0 |
| 2026-06-22 | BIOS Memory SPV I, LP | Director | Buy | 25,000 | $0 |
| 2026-06-22 | BIOS Fund I, LP | Director | Buy | 25,000 | $0 |
| 2026-06-22 | BIOS Fund I QP, LP | Director | Buy | 25,000 | $0 |
| 2026-06-22 | BIOS Fund II, LP | Director | Buy | 25,000 | $0 |
| 2026-06-22 | RICHSTONE ELLEN B | Director | Buy | 25,000 | $0 |
| 2026-06-22 | Fletcher Aaron G.L. | Director | Buy | 25,000 | $0 |
| 2026-06-22 | Bios Equity Partners II, LP | Director | Buy | 25,000 | $0 |
| 2026-06-22 | Bios Equity Partners, LP | Director | Buy | 25,000 | $0 |
| 2026-06-22 | BIOS Advisors GP, LLC | Director | Buy | 25,000 | $0 |
| 2026-06-22 | BIOS Capital Management, LP | Director | Buy | 25,000 | $0 |
| 2026-06-22 | BIOS Fund II QP, LP | Director | Buy | 25,000 | $0 |
| 2026-05-04 | Doyle John Brendan | Chief Financial Officer | Sell | 8,567 | $10,966 |
| 2026-04-20 | Caggiano Anthony | Chief Medical Officer | Buy | 10,000 | $11,100 |
| 2026-04-20 | Ricciardi Lisa | CEO & President | Buy | 9,175 | $10,092 |
| 2026-04-20 | Doyle John Brendan | Chief Financial Officer | Buy | 10,000 | $11,300 |
| 2026-02-18 | Ricciardi Lisa | CEO & President | Sell | 5,850 | $6,552 |
| 2026-02-18 | Caggiano Anthony | Chief Medical Officer | Sell | 4,680 | $5,242 |
| 2026-02-18 | Doyle John Brendan | Chief Financial Officer | Sell | 1,560 | $1,747 |
| 2026-02-05 | Ricciardi Lisa | CEO & President | Sell | 26,036 | $29,160 |
| 2026-02-05 | Doyle John Brendan | Chief Financial Officer | Buy | 200,000 | $0 |
| 2026-02-05 | Doyle John Brendan | Chief Financial Officer | Sell | 26,921 | $27,729 |
| 2026-02-05 | Ricciardi Lisa | CEO & President | Buy | 800,000 | $0 |
Source: SEC Form 4 filings · as of 2026-06-22